These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3575747)

  • 21. [Heterogeneity of brain aging: from senile dementia to successful aging].
    Zhang MY
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2953-4. PubMed ID: 16324376
    [No Abstract]   [Full Text] [Related]  

  • 22. The validity of animal models in the search for drugs for the aging brain.
    Pepeu G; Pepeu IM; Casamenti F
    Drug Des Deliv; 1990 Dec; 7(1):1-10. PubMed ID: 2096830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain aging and memory: new findings help differentiate forgetfulness and dementia.
    D'Esposito M; Weksler ME
    Geriatrics; 2000 Jun; 55(6):55-8, 61-2. PubMed ID: 10872346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Deficits in inhibitory processes in normal aging and patients with Alzheimer's disease: a review].
    Fournet N; Mosca C; Moreaud O
    Psychol Neuropsychiatr Vieil; 2007 Dec; 5(4):281-94. PubMed ID: 18048106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical basis of functional neuroteratology. Permanent effects of chemicals on the developing brain. Proceedings of the 15th International Summer School of Brain Research. Amsterdam, The Netherlands, August 31 to September 4, 1987.
    Prog Brain Res; 1988; 73():1-565. PubMed ID: 3420287
    [No Abstract]   [Full Text] [Related]  

  • 26. [Brain research in Germany from the gerontologic viewpoint. Problem status and international comparison].
    Hoyer S
    Z Gerontol; 1985; 18(6):318-21. PubMed ID: 4096075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.
    Blalock EM; Chen KC; Stromberg AJ; Norris CM; Kadish I; Kraner SD; Porter NM; Landfield PW
    Ageing Res Rev; 2005 Nov; 4(4):481-512. PubMed ID: 16257272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional activation imaging in aging and dementia.
    Prvulovic D; Van de Ven V; Sack AT; Maurer K; Linden DE
    Psychiatry Res; 2005 Nov; 140(2):97-113. PubMed ID: 16257186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D
    J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aging--senescence--dementia].
    Imahori K
    Nihon Ronen Igakkai Zasshi; 2000 Sep; 37(9):687-92. PubMed ID: 11109834
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemical transmission in the brain. The role of amines, amino acids and peptides. Proceedings of the 12th International Summer School of Brain Research, Amsterdam, The Netherlands, August 31 to September 4, 1981.
    Prog Brain Res; 1982; 55():1-489. PubMed ID: 6298862
    [No Abstract]   [Full Text] [Related]  

  • 32. The neurophysiology of dementia.
    Levy R
    Br J Psychiatry; 1975; Spec No 9():119-23. PubMed ID: 126709
    [No Abstract]   [Full Text] [Related]  

  • 33. Location, location, location!
    Royall DR
    Neurobiol Aging; 2007 Oct; 28(10):1481-2; discussion 1483. PubMed ID: 17055613
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
    Sauer J; ffytche DH; Ballard C; Brown RG; Howard R
    Brain; 2006 Jul; 129(Pt 7):1780-8. PubMed ID: 16670180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.
    Weller RO; Cohen NR; Nicoll JA
    Panminerva Med; 2004 Dec; 46(4):239-51. PubMed ID: 15876980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of dementias and implications for therapy.
    Roy OW; Cohen NR; Nicoll JA
    Indian J Pathol Microbiol; 2005 Jul; 48(3):289-99. PubMed ID: 16761736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon and CCK in human brain: controls and patients with senile dementia of Alzheimer type.
    Sanders DJ; Zahedi-Asl S; Marr AP
    Prog Brain Res; 1982; 55():465-71. PubMed ID: 7163497
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognitive function at menopause: neuroendocrine implications for the study of the aging brain.
    Costa A; Nappi RE; Sinforiani E; Bono G; Poma A; Nappi G
    Funct Neurol; 1997; 12(3-4):175-80. PubMed ID: 9218973
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory functioning in Alzheimer's disease.
    Amieva H; Phillips LH; Della Sala S; Henry JD
    Brain; 2004 May; 127(Pt 5):949-64. PubMed ID: 14645147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    Keller JN
    Ageing Res Rev; 2006 Feb; 5(1):1-13. PubMed ID: 16084778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.